Lentivirus News and Research

RSS

Lentivirus is a genus of slow viruses of the Retroviridae family, characterized by a long incubation period.

Study reveals how SARS-CoV-2 hijacks lung cells to drive COVID-19 severity

Researchers identified how SARS-CoV-2 targets and manipulates specific lung cells, using innovative techniques to trace the virus's impact on the cells' gene expression, revealing insights into early COVID-19 pathogenesis.

14 Apr 2024

From farm to pharmacy: Transgenic cow milk as a new source of human insulin

A team of researchers from Brazil constructed a lentivirus vector with expression specific for mammary glands and carrying the gene for human insulin.

21 Mar 2024

Novel screening system reveals sperm cell development and health at the molecular level

A novel screening system developed at Kyoto University enables researchers to investigate sperm cell development and health at the molecular level.

5 Mar 2024

Bio-Rad launches vericheck ddPCR replication competent lentivirus and replication competent AAV kits for cell and gene therapy production

Rapid, Sensitive, and Validated Detection of Viral Replication Genes Using Droplet Digital™ PCR During Cell and Gene Therapy Production.

From Bio-Rad Laboratories 27 Feb 2024

Asimov launches LV Edge Packaging System to optimize lentivirus production

New off-the-shelf system reduces the cost and risk of lentiviral (LV) production for cell and gene therapy developers.

From Asimov 29 Jan 2024

Key protein EPAC1 found to regulate brown fat growth, offering obesity treatment potential

Study reveals that EPAC1 protein plays a crucial role in regulating the growth of brown and beige adipose tissue, offering potential avenues for treating obesity and improving cardiometabolic health.

11 Jan 2024

CRISPR cures on the horizon: Breakthrough center aims to heal rare, deadly genetic diseases

Children and adults with rare, deadly genetic diseases have fresh hope for curative therapies, thanks to a new collaboration between the Innovative Genomics Institute (IGI) and Danaher Corporation, a global life sciences and diagnostics innovator.

9 Jan 2024

Refeyn launches KaritroMP for rapid and reproducible characterization of large viral vectors

Refeyn, a leader in mass photometry technology, announces the launch of its macro mass photometry platform, KaritroMP.

From Refeyn 4 Dec 2023

Researchers discover new gene targets for precision oncology in esophageal cancer

Researchers have identified a new way to screen genes that cause several different types of cancers to grow, identifying particularly promising targets for precision oncology in oral and esophageal squamous cancers.

28 Nov 2023

Study finds diet-derived trans-vaccenic acid boosts anti-tumor immunity

Dietary components that impact anti-tumor immunity.

28 Nov 2023

Speeding up Alzheimer's research: Progerin turbocharges cellular models for quicker drug screening

The study reveals that introducing progerin, a protein associated with accelerated aging, into cellular models of Alzheimer's Disease (AD) can hasten the development of AD-related traits. This innovative approach offers a more efficient method for studying AD mechanisms, potentially accelerating the discovery of new treatments.

31 Oct 2023

Turning brain immune cells into neurons restores brain function after stroke-like injury in mice

Researchers at Kyushu University have discovered that turning brain immune cells into neurons successfully restores brain function after stroke-like injury in mice.

18 Oct 2023

Aerosolized ACE2 neutralizes COVID-19 variants in lab and mice tests

Researchers from the University of Texas Southwestern have developed an aerosolized, mutated form of ACE2 that effectively neutralizes various SARS-CoV-2 variants in both cell cultures and mice. The study suggests that this modified ACE2 has promising preventive and therapeutic potential against COVID-19, especially with its easy aerosolized administration.

28 Sep 2023

Unlocking the secret soldiers: How dendritic cells could revolutionize cancer immunotherapy

A recent review in the journal Immunity delves into the crucial role of dendritic cells (DCs) in shaping T-cell responses in cancer, highlighting their importance in both priming anti-tumor immunity and in ongoing immune interactions within tumors. The findings underscore the potential of DCs as key targets for next-generation cancer immunotherapies.

18 Sep 2023

Lentivirus News and Research

Further Reading

Study reveals how SARS-CoV-2 hijacks lung cells to drive COVID-19 severity

From farm to pharmacy: Transgenic cow milk as a new source of human insulin

Novel screening system reveals sperm cell development and health at the molecular level

Bio-Rad launches vericheck ddPCR replication competent lentivirus and replication competent AAV kits for cell and gene therapy production

Asimov launches LV Edge Packaging System to optimize lentivirus production

Key protein EPAC1 found to regulate brown fat growth, offering obesity treatment potential

CRISPR cures on the horizon: Breakthrough center aims to heal rare, deadly genetic diseases

Refeyn launches KaritroMP for rapid and reproducible characterization of large viral vectors

Researchers discover new gene targets for precision oncology in esophageal cancer

Study finds diet-derived trans-vaccenic acid boosts anti-tumor immunity

Speeding up Alzheimer's research: Progerin turbocharges cellular models for quicker drug screening

Turning brain immune cells into neurons restores brain function after stroke-like injury in mice

Aerosolized ACE2 neutralizes COVID-19 variants in lab and mice tests

Unlocking the secret soldiers: How dendritic cells could revolutionize cancer immunotherapy

Researchers characterize new SARS-CoV-2 BA.2.86 variant neutralization by monoclonal antibodies

Novavax's updated XBB.1.5 vaccine shows promising cross-neutralizing antibodies against new COVID-19 variants

Hmga1 protein could be an important therapeutic target for osteoporosis

New brain-penetrant agonist shows promise in protecting dopamine neurons for Parkinson's disease treatment

Eternal youth? Chemical cocktails prove effective in cell age reversal

Researchers screen 16 UK native bat species for coronaviruses with zoonotic potential

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News